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Background: Spinal cord injury (SCI) is reported to occur in 3–12% of thoracic endovascular aortic repair 
(TEVAR) cases, but is a potentially preventable complication of TEVAR for thoracoabdominal pathologies. 
Although many strategies have been devised to reduce the incidence of SCI, the effectiveness of prophylactic 
cerebrospinal fluid drainage (CSFD) and left subclavian artery (LSA) revascularization remains controversial.
Methods: From 2012 to 2014, 162 patients underwent TEVAR at a single institution. We prospectively 
collected and retrospectively reviewed the data of 81 patients who underwent preoperative CSFD among 
the 162 patients. LSA revascularization was routinely used when LSA need to be covered. Preoperative 
characteristics, intraoperative variables, and outcomes were analyzed.
Results: The mean (SD) age of the patients was 60.6 (12.5) years, and 57 patients (70%) were male. 
Twenty-five patients (31%) presented with degenerative aneurysm; 48 (59%), type B dissection; 5, (6%) 
penetrating aortic ulcer; and 3 (4%), intramural hematoma. Thirty-six patients (44%) underwent LSA 
revascularization before TEVAR. Two (2.5%) of the patients who underwent preoperative CSFD had SCI, of 
whom one recovered ambulatory status at discharge after hypertensive therapy and another had a permanent 
disability. Prior abdominal aortic aneurysm (AAA) repair tended to relate to SCI (P=0.065), and preoperative 
aortic rupture was a significant independent risk factor of SCI (P=0.002).
Conclusions: Preemptive CSFD as an adjunctive procedure to TEVAR proved to be more effective 
than selective use of CSFD in other prior reports of SCI cases. Preoperative CSFD is recommended as a 
prophylactic procedure in patients at high risk of SCI during TEVAR.
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Introduction
Thoracic endovascular aortic repair (TEVAR) has 
revolutionized the treatment of pathologies of the thoracic 
aorta, including thoracic aortic aneurysms, penetrating 
atherosclerotic ulcers, traumatic thoracic aortic injuries, and 
acute complicated type B aortic dissections, with reduced 
perioperative mortality and morbidity, in comparison with 
open repair (1). Although the incidence of spinal cord 
injury (SCI) after TEVAR is lower than that after open 
repair, it still ranges from 3% to 12% (2) and can lead to 
profound long-term disability. Various strategies have been 
suggested to reduce the risk of SCI, including cerebrospinal 
fluid drainage (CSFD) and maintaining an increased mean 
arterial pressure (MAP) to improve spinal cord perfusion. 
Protective protocols for SCI are generally used with open 
repair of thoraco-abdominal aortic aneurysms (TAAA), but 
these protocols are less defined for TEVAR (2). Current 
guidelines recommend the use of prophylactic CSFD 
with TEVAR for long-segment descending thoracic aortic 
coverage in patients with prior abdominal aortic aneurysm 
(AAA) repair (3). However, these guidelines are based on 
evidence from open repair of thoracic aortic pathologies, 
not from TEVAR (4,5). In addition, systematic reviews 
have failed to show that CSFD prevents SCI in TEVAR (5). 
Consequently, the protocols for SCI prevention in TEVAR 
vary widely, with some centers advocating the routine 
use of CSFD and others advocating the use of selective 
preoperative or postoperative CSFD (6).
The purpose of this study was to evaluate the overall 
incidence of SCI and determine the efficacy of prophylactic 
CSFD in preventing SCI after TEVAR.
Methods
Our institutional review board approved this study 
and waived the need for informed consent owing to its 
retrospective nature (Yonsei IRB No. 3-2014-0144).
Patients and data source
From January 2012 to August 2014, 162 patients underwent 
TEVAR for various aortic pathologies at Gangnam 
Severance Hospital, Yonsei University College of Medicine 
in Seoul, Korea. Among these patients, 81 underwent 
preoperative CSFD, whose data we retrospectively 
reviewed.
Preoperative, intraoperative, and postoperative variables 
were extracted from the computerized database of the 
hospital, with additional information obtained through a 
retrospective record review. Preoperative data included 
patient demographics [age, sex, and body mass index 
(BMI)], comorbidities (diabetes, hypertension, previous 
cerebrovascular accident, coronary artery occlusive disease, 
chronic obstructive pulmonary disease, peripheral artery 
occlusive disease, old cerebrovascular accident, and carotid 
artery disease), previous operations of the abdominal aorta, 
a dominant vertebral artery on computed tomography 
(CT), serum creatinine level (mg/dL), hemoglobin level 
(g/dL), and the time of CSFD insertion. Intraoperative 
data included the level of the landing zone, left subclavian 
artery (LSA) coverage, LSA revascularization, the number 
of stent grafts used, the type of stent grafts used, MAP 
at deployment, and final endoleak. Postoperative data 
included the incidence of paraplegia, CSFD complications, 
the distal level of the stent graft, and the length of aortic 
coverage on postoperative CT. The distal level of the stent 
graft was measured by using the spinal level, and the stent 
graft length of aortic coverage was measured manually 
on postoperative CT. Operative mortality was defined 
as in-hospital mortality or mortality within 30 days post 
operation. Survival data were obtained from a hospital chart 
review.
Clinical practice
All the operations were performed under general 
anesthesia in a hybrid operating room (OR). The need for 
perioperative adjuncts (e.g., CSFD, LSA revascularization, 
and percutaneous or open vessel access) was at the discretion 
of the attending surgeon and the interventional radiologist. 
Systemic heparinization (100 U/kg) was applied in all the 
patients to achieve an appropriate activated clotting time 
of >300 seconds. Oversized devices with diameters 10% to 
15% greater than that of the aortic diameter of the proximal 
portion of the pathologic aorta were used.
CSFD indication and SCI prevention strategy
CSFDs were performed in high-risk patients for SCI during 
TEVAR. High-risk patients were defined as those who 
(I) received coverage of the LSA; (II) received extensive 
coverage of long segments of the thoracic aorta (length 
of the coverage by stent graft, >30 cm); (III) received 
prior downstream aorta repair; (IV) had compromising 
important intercostal (T8-L1), vertebral, pelvic and 
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hypogastric collaterals; or (V) had a shaggy aorta (6). 
We performed CSFD prior to TEVAR in the patients 
with a high risk of SCI, including emergent cases. CSF 
was drained intermittently to achieve CSF pressures of 
<10 mmHg in the OR and intensive care unit (ICU). If no 
specific neurological problems occurred, the CSFD catheter 
was removed 48 hours after the procedures. However, if 
delayed neurological deficit occurred, CSF must be drained 
to achieve an intracranial pressure of <5 mmHg and to 
maintain a MAP of >90 mmHg (7).
Definition of SCI
SCI was defined as any new lower extremity sensory and/
or motor deficit not attributable to epidural hematoma, 
peripheral  neuropathy, or intracranial  pathology. 
Postoperative neurological examination was performed 
in the OR or ICU whenever possible. Patients who had 
any new neurological deficit at the first postoperative 
neurological examination were classified as having an 
immediate SCI. Delayed SCI was defined as a newly 
developed SCI after the first postoperative neurological 
examination (8).  All  CSFDs were inserted by the 
neurosurgery team at our hospital. At the beginning of the 
study period, the CSFD was inserted the day before the 
operation in the general ward, but this was changed to take 
place in the OR after the induction of general anesthesia for 
the patients’ convenience and prevention of puncture site 
infection. LSA revascularization was routinely performed 
when the LSA was covered, except for emergent cases. All 
the patients were admitted to the ICU postoperatively.
Statistical analyses
Continuous variables were summarized by using mean 
values and standard deviations. The categorical variables 
were summarized by using frequencies and percentages. 
Independent risk factors of SCI were identified using 
univariate and multivariate logistic regression. All statistical 
analyses were performed using the Statistical Package for 
Social Sciences version 23 (SPSS, Chicago, Ill, USA).
Results
Demographics
Patient demographics and comorbidities, as well as the types 
of aortic pathology, are shown in Table 1. The mean patient 
age was 60.6±12.5 years. Of the patients, 57 (70%) were 
male and 24 (30%) were female. Fifteen patients underwent 
emergency operations. Four patients (4.9%) had previously 
undergone abdominal aorta replacement.
Procedural details
In 81 patients, 150 stent grafts were deployed, including 
the Zenith TX2 Proform (Cook, Bloomington, Ind, USA) 
in 46 (57%) patients, the Valiant Captivia (Medtronic, 
Minneapolis, Minn, USA) in 33 (41%), and both the TX2 
and Valiant in 2 (3%). Twenty-five patients (31%) needed 
1 stent graft; 45 (56%), 2 grafts; 9 (11%), 3 grafts; and 
2 (3%), 4 grafts. One of the two patients, who required 
4 stent grafts, underwent zone 0 TEVAR, and the total 
treatment length was 28.87 cm. The other patient requiring 
4 stent grafts underwent zone 3 TEVAR with abdominal 
aorta to the superior mesenteric artery bypass, and the 
total treatment length was 32.61 cm. These two patients 
required four stent grafts, not only due to the long coverage 
length that was needed, but more so due to the difference in 
diameter between the proximal landing zone and the distal 
landing zone due to chronic aortic dissection. The mean 
stent graft length for aortic coverage was 22.4±6.2 cm. The 
proximal landing zones are shown in Figure 1. The level of 
the distal landing zone was checked by using postoperative 
CT (Figure 2). Eleven patients had endoleaks on their final 
angiogram, including 2 patients with type Ia endoleak, 
5 with type Ib endoleak, and 4 patients with type III endoleak. 
None of the patients required conversion to open surgery. The 
endoleak recovered spontaneously in all the patients. Twenty-
four patients (30%) underwent CSFD in the general ward 
the day before TEVAR, while 57 patients (70%) underwent 
CSFD at the OR after general anesthesia, with a mean 
time of CSFD insertion at the OR of 34.3±19.8 minutes. 
Of 36 patients (44%) who needed LSA coverage and 
underwent LSA revascularization, 35 underwent LSA 
bypass and the remaining patient underwent the chimney 
technique. The procedural data are shown in Table 2.
Perioperative outcomes
The perioperative data are shown in Table 3. The mean 
durations of hospital and ICU stay were 13.3 and 2.2 days, 
respectively. The mean duration of indwelling CSFD was 
3 days. Four patients had postoperative cerebrovascular 
accidents, two of whom required rehabilitation because 
of unilateral weakness. All the 4 patients had antiplatelet 
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Table 1 Patient demographics (N=81)
Variables Value
Age [years (SD)] 60.6 (12.5)
BMI [kg/m2 (SD)] 24.2 (3.1)
Preop creatinine [ml/dL (SD)] 0.9 (1.7)
Preop hemoglobin [g/dL (SD)] 12.7 (1.6)
Male 57 [70]
Emergency operation 15 [19]
Normal sinus rhythm 54 [67]
Aortic rupture 4 [5]
Acute pathology 12 [15]
Smoking 29 [36]
HTN 68 [84]
DM 9 [11]
CAOD 4 [5]
PTCA 3 [4]
CABG 0 [0]
PAOD 0 [0]
COPD 1 [1]
Old CVA 3 [4]
Carotid stenosis 2 [3]
ARF 4 [5]
CRF 7 [9]
Marfan syndrome 3 [4]
Prior aorta operation 34 [42]
Ascending aorta replacement 7
Hemi-arch replacement 3
Total arch replacement (TAR) 15
Descending thoracic aorta replacement 1
Abdominal aorta replacement 2
TEVAR zone 1 1
TEVAR zone 2 3
AAA + TEVAR 1
TAR + TAAA 1
Vertebral artery——left dominant 43 [53]
Aortic pathology 81
 Aortic dissection DeBakey Type I (s/p) 2 [3]a
 Aortic dissection DeBakey Type III 46 [57]b
 Aortic aneurysm 25 [31]
 PAU 5 [6]
 IMH 3 [4]
Data expressed as number [%], unless noted otherwise. a, two patients underwent prior operations of the ascending aorta; b, 11 patients (13.6%) 
were acute, 35 patients (43.2%) were chronic. BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; CAOD, coronary artery occlusive 
disease; PTCA, percutaneous transluminal coronary angioplasty; CABG, coronary artery bypass graft; PAOD, peripheral artery occlusive disease; 
COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; AFR, acute renal failure; CRF, chronic renal failure; AAA, abdominal 
aortic aneurysm; TAAA, thoracoabdominal aorta replacement; s/p, status/post; PAU, penetrating atherosclerotic ulcer; IMH, intramural hematoma.
2408 Song et al. Spinal drainage during thoracic endovascular aortic repair
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(8):2404-2412jtd.amegroups.com
medication. Although 23 patients (28%) experienced 
C S F D - r e l a t e d  c o m p l i c a t i o n s ,  m o s t  h a d  m i n o r 
complications (spinal headache in 11, puncture-site pain 
in 5, puncture-site infection in 1, radiating leg pain in 1, 
and intracranial hypotension in 3), except 2 patients with 
subdural hematoma. Of the two cases, one seemed to be 
related to the use of heparin right after catheter insertion. 
The other was due to intracranial hypotension. All the 
patients with CSFD-related complications recovered 
after proper conservative management, except for 
1 patient who had to undergo an operation due to subdural 
hematoma. SCI occurred in 2 patients (2.5%). Of those 
patients, one recovered to ambulatory status at discharge 
Figure 1 The proximal landing zone.
Figure 2 The level of the distal landing zone.
Table 3 Perioperative outcomes
Variables Value
Hospital stay [days (SD)] 13.3 (16.3)
ICU stay [days (SD)] 2.2 (4.2)
CSFD indwelling [days (SD)] 2.9 (1.1)
Total length of aortic coverage [cm (SD)] 22.4 (6.2)
30-day mortality 2 [3]
Reintubation 3 [4]
Bleedinga 2 [3]
Post ARF 4 [5]
Pulmonary complication 3 [4]
Puncture site infection 2 [3]
Access vessel complicationb 3 [4]
Post CVA 4 [5]
LSA revascularization related complications 0
CSFD-related complications 23 [28]
Spinal headache 11
Puncture site pain 5
Puncture site infection 1
Radiating leg pain 1
Intracranial hypotension 3
Subdural hemorrhage 2
SCI 2 [3]
Transient motor weakness of leg 1 [1]
Paraplegia 1 [1]
Data expressed as number (%), unless noted otherwise. a, one 
patient had femoral cut down site bleeding and one patient 
had femoral Perclose site bleeding; b, two patients had femoral 
artery pseudoaneurysm and one patient had femoral artery 
thrombosis. ICU, intensive care unit; CSFD, cerebrospinal 
fluid drainage; ARF, acute renal failure; CVA, cerebrovascular 
accident; LSA, left subclavian artery; SCI, spinal cord ischemia.
Table 2 Procedural data
Variables Value
Implanted stent grafts [number (SD)] 1.9 (0.7)
Operation time [minutes (SD)] 140.8 (108.9)
CSFD insertion time at the OR [minutes (SD)] 34.3 (19.8)
CSFD insertion at the OR 57 [70]
Mean BP during deployment [mmHg (SD)] 73.9 (9.9)
Post-deployment mean BP [mmHg (SD)] 93.5 (12.8)
LSA revascularizationa 36 [44]
Final endoleak 11 [14]
Type Ia 2 [3]
Type Ib 5 [6]
Type III 4 [5]
Data expressed as number (%), unless noted otherwise. a, LSA 
bypass in 35 patients and chimney technique in 1 patient. OR, 
operation room; BP, blood pressure; LSA, left subclavian artery.
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after hypertensive therapy and the other had a permanent 
disability. No complications related to LSA revascularization 
occurred. Two patients (2.5%) died within 30 days after 
TEVAR, but neither had SCI. One of the patients died 
because of multiorgan failure, and the other patient died 
of an unknown cause after discharge to home. The mean 
follow-up durations of the patients who developed and 
those who did not develop SCI after TEVAR were 4.42±0.21 
and 9.70±7.83 months, respectively (P=0.467).
Risk factor analysis for SCI
Among the 81 patients with CSFD, 2 (2.5%) developed 
SCI after TEVAR. We analyzed the risk factors of SCI. 
Univariate logistic regression analysis revealed that sex, age, 
BMI, emergency operations, previous aortic operations, 
postoperative ARF, postoperative CVA, postoperative 
pulmonary complications, the level of the distal landing 
zone, and the length of aortic coverage were not significant 
prognostic factors of SCI. Previous AAA repair tended to 
be related to SCI (P=0.065). Multivariate logistic regression 
analysis revealed that preoperative aortic rupture was a 
significant independent risk factor of SCI (P=0.002; Table 4).
Discussion
SCI is a critical complication of open thoracic aortic 
surgery and TEVAR. SCI has been reported in up to 20% 
of open thoracic aortic surgeries (5). Various strategies to 
reduce SCI have been devised, including CSFD, cooling, 
intercostal vessel reimplantation, and increased MAP in 
open aortic surgery. A relationship between CSF pressure 
and the development of SCI during repairs of the thoracic 
aorta have been suggested in many studies. The rationale 
for CSFD is that spinal cord perfusion pressure is the 
difference between MAP and the CSF pressure (9). The 
use of prophylactic CSFD during open aortic surgery is 
controversial, and many studies have been conducted on this 
subject. Coselli et al. demonstrated a significant decrease in 
SCI when using CSFD in a large randomized trial (13% vs. 
2.6%, P=0.03) (10). The benefit of prophylactic CSFD in 
open aortic surgery has been established by 2 meta-analyses 
(9,11). In TEVAR, the risk of SCI has not been completely 
established, with reported incidence rates ranging from 
3% to 12% (2,12), and spinal cord-protective protocols are 
less defined than open aortic surgeries. Many studies have 
reported the incidence of SCI after TEVAR with CSFD, 
but no randomized trials have examined this issue. In the 
literature, risk factors that have been associated with SCI 
after TEVAR include emergency surgery, treatment of a 
long portion of the aortic segment, dissection, rupture, 
advanced age, and prior abdominal aortic operation or 
stent graft (7). The exclusion of intercostal arteries (T7-L1) 
supplying the anterior spinal artery is associated with 
neurological events, and long coverage of the thoracic 
aorta is a significant risk factor of SCI (13). With the 
increasing application of TEVAR for various thoracic aortic 
pathologies, the use of CSFD is becoming more important 
Table 4 Risk factor analysis for SCI
Variable
Univariate Multivariate
P value Exp (B) 95% CI P value Exp (B) 95% CI
Female 0.898 1.174 0.101–13.598
Age (years) 0.139 1.135 0.960–1.342
BMI (kg/m2) 0.281 0.789 0.512–1.214
Emergency 0.520 2.250 0.190–26.582
Preop aortic rupture 0.002 75.000 4.648–1,210.174 0.002 75.000 4.648–1,210.174
Prior aorta operation 0.811 0.742 0.064–8.540
AAA operation 0.065 12.333 0.860–176.951 0.335 6.235 0.151–257.960
Graft distal level 0.324 0.571 0.187–1.741
Length of coverage (cm) 0.544 0.933 0.745–1.167
SCI, spinal cord injury; CI, confidence interval; BMI, body mass index; ARF, acute renal failure; CVA, cerebrovascular accident; pul Cx, 
pulmonary complication.
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for minimizing neurological deficits. However, no consensus 
has been reached among vascular surgeons about the best 
strategy for CSFD.
Several studies support the use of CSFD as an adjunct, 
with few of these studies demonstrating associated 
complications (14-19). The overall complication rate of 
CSFD has been reported to be approximately 5%. The 
most severe complication was intracranial hemorrhage, 
which has been associated with a mortality rate as high as 
50% (18,20).
During our earlier experience with TEVAR, we used 
CSFD more selectively in patients treated for a long 
portion of the aortic segment. Subsequently, we routinely 
used CSFD in our high-risk TEVAR patients, including 
emergent cases. In our series of 81 patients, 23 patients 
(28.4%) had CSFD-related complications, but most 
recovered quickly, except one patient who required surgery 
for subdural hemorrhage (SDH). This patient recovered 
well after surgery. Our study included minor complications 
such as mild headaches and pains, so the overall incidence of 
CSFD-related complications was high. Two patients (2.5%) 
who received CSFD developed SCI. One of the patients 
had transient motor weakness of the leg, while the other 
had paraplegia (Table 3). Among the patients who did not 
receive preoperative CSFD, one developed SCI. Wong et al. 
reported in a systematic review that the overall incidence of 
SCI after TEVAR was 3.88% [95% confidence interval (CI), 
2.95–4.85]. The overall rate of SCI in our study was 1.85% 
in the patients with or without CSFD. Wong et al. indicated 
that the use of prophylactic CSFD was difficult to define 
on the basis of the existing literature. Prophylactic CSFDs 
were only used in patients at high risk of perioperative SCI, 
so the analysis had an inherent bias (5). Arnaoutakis et al. 
reported that their strategy using CSFD as an adjunctive 
procedure for TEVAR resulted in lower rates of SCI 
than those reported in prior studies that used selective 
CSFD, as well as increased unadjusted survival. Thus, they 
recommended preoperative CSFD for all eligible patients 
whenever clinically feasible (21). With the use of routine 
CSFD in this study, the incidence rate of permanent SCI in 
the high-risk group was 1.2%. This rate was lower than that 
reported in prior studies. Thus, prophylactic CSFD is a safe 
and effective therapy for reducing the risk of SCI, in spite 
of the related complications. The overall rate of CSFD-
related complications, including minor complications, was 
28%. Greater caution is needed to reduce the incidence of 
complications.
The LSA is the main artery to the left upper limb. LSA 
occlusion may cause various complications, including 
varying degrees of upper limb ischemia, cerebrovascular 
accident, and SCI (22). The LSA has 3 major branches 
associated with TEVAR, namely the left internal mammary 
artery, vertebral artery, and costocervical trunk. The 
vertebral artery and costocervical trunk contribute to 
spinal cord perfusion. Thus, the LSA coverage during 
TEVAR may induce SCI by reducing spinal blood flow (23). 
Spinal cord perfusion depends on more than one source 
of blood supply (22). Buth et al. demonstrated the 
clinical significance of this source of collateral perfusion 
of the spinal cord. They reported that the coverage 
of the LSA without revascularization was significantly 
associated with perioperative paraplegia or paraparesis 
in the EUROSTAR registry. In their study, neurological 
complications developed in 8.4% of the patients without 
LSA revascularization but in none of the patients with 
prophylactic LSA revascularization (P=0.049) (24). Cooper 
et al. demonstrated that the risk of SCI was increased in 
patients who required LSA coverage in a meta-analysis 
and systematic review (22). Several review studies support 
routine preemptive LSA revascularization (22,23,25,26). 
The Society for Vascular Surgery Practice guidelines 
recommend routine preoperative revascularization in 
patients who need LSA coverage during TEVAR, despite 
the very-low-quality evidence (grade 2, level C) (27). 
Peterson et al. demonstrated that LSA revascularization 
could be performed with a relatively low risk (28). 
In our study, no complications associated with LSA 
revascularization occurred. With the routine use of CSFD 
and LSA revascularization in this study, the incidence rate 
of SCI was lower than that reported in prior studies.
The mechanism underlying SCI is not completely 
understood but may relate to reperfusion injury and 
hemodynamic derangements. Many studies reported that 
an increased length of aortic coverage during TEVAR 
was associated with SCI (2,29-31). Keith et al. reported 
that longer stent graft coverage of the thoracic aorta was 
associated with an increased incidence of SCI, but no 
specified length was defined as a factor of increased risk of 
SCI (2). We demonstrated that preoperative aortic rupture 
was a risk factor of SCI. In patients with thoracic aortic 
rupture, more-aggressive strategies have been considered 
for preventing SCI, such as maintaining the MAP between 
80 and 100 mmHg right after stent-graft deployment (7). In 
the literature, previous AAA operation and the length of the 
stent graft are known risk factors of SCI after TEVAR, but 
these were not associated with SCI in our study. This may 
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be due to the small sample size used in our study.
Despite the perioperative advantages of TEVAR over 
open aortic repair, SCI remains a devastating complication 
that has a profound influence on long-term outcomes. 
In our data, patients who developed and those who did 
not develop SCI after TEVAR had mean lengths of 
postoperative survival of 4.42±0.21 and 9.70±7.83 months, 
respectively (P=0.467).
Limitations
Our study has some limitations. Its retrospective nature 
limited the variables available for analysis; therefore, some 
selection bias or unidentified confounding bias may have 
influenced the results. The patients in the study population 
were heterogeneous (including both emergency and elective 
patients with various aortic pathologies). In addition to the 
relatively small sample size, the selection of patients from 
a single center may have limited the generalizability of our 
results. We did not assess all possible causes of SCI and 
did not analyze the complete hemodynamic data following 
discharge.
Conclusions
Our preemptive CSFD as an adjunctive procedure 
to TEVAR proved to have better outcomes than the 
selective use of CSFD in other prior reports of SCI cases. 
Preoperative CSFD is recommended as a prophylactic 
procedure in patients at high risk of SCI during TEVAR.
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